Join us for the Policy Summit Sept. 25-26 at the Washington Marriott Georgetown in Washington, D.C.!
During the 2025 Annual Meeting, Dr. Kaminsky presented results from a phase 1 clinical trial describing a vaccine for cocaine addiction.
On this episode of Soundbites of the Annual Meeting, we talked to Stephen Kaminsky, PhD, professor of research in genetic medicine at Weill Cornell Medical College, and lead author of a phase 1 clinical trial studying a new vaccine for cocaine addiction.
In his conversation with ASGCT's Communications Committee Chair, Lynnea Olivarez, Dr. Kaminsky discusses:
How the vaccine works and how its approach is different from other treatments
Safety results from the unblinded data
Implications this vaccine could have for other substance use disorders
Listen and subscribe to the ASGCT Podcast Network so you don't miss any episodes!
Sept. 25-26, 2025 | Washington, D.C.
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico